175 related articles for article (PubMed ID: 11123871)
1. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol.
Kumar P; Robbins KT
Curr Oncol Rep; 2001 Jan; 3(1):59-65. PubMed ID: 11123871
[TBL] [Abstract][Full Text] [Related]
2. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
Robbins KT; Kumar P; Harris J; McCulloch T; Cmelak A; Sofferman R; Levine P; Weisman R; Wilson W; Weymuller E; Fu K
J Clin Oncol; 2005 Mar; 23(7):1447-54. PubMed ID: 15735120
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma.
Ackerstaff AH; Tan IB; Rasch CR; Balm AJ; Keus RB; Schornagel JH; Hilgers FJ
Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1185-90. PubMed ID: 12365891
[TBL] [Abstract][Full Text] [Related]
4. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Kovács AF; Mose S; Böttcher HD; Bitter K
Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
Yoshizaki T; Wakisaka N; Murono S; Kondo S; Shimizu Y; Takanaka T; Sanada J; Terayama N; Matsui O; Furukawa M
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):754-61. PubMed ID: 17987781
[TBL] [Abstract][Full Text] [Related]
6. RADPLAT: an alternative to surgery?
Alkureishi LW; de Bree R; Ross GL
Oncologist; 2006 May; 11(5):469-80. PubMed ID: 16720847
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.
Robbins KT; Kumar P; Regine WF; Wong FS; Weir AB; Flick P; Kun LE; Palmer R; Murry T; Fontanesi J; Ferguson R; Thomas R; Hartsell W; Paig CU; Salazar G; Norfleet L; Hanchett CB; Harrington V; Niell HB
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):263-71. PubMed ID: 9226312
[TBL] [Abstract][Full Text] [Related]
8. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
10. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation.
Newman LA; Robbins KT; Logemann JA; Rademaker AW; Lazarus CL; Hamner A; Tusant S; Huang CF
Head Neck; 2002 Jan; 24(1):68-77. PubMed ID: 11774405
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E
J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053
[TBL] [Abstract][Full Text] [Related]
12. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
[TBL] [Abstract][Full Text] [Related]
13. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.
Winquist E; Agbassi C; Meyers BM; Yoo J; Chan KKW;
J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):29. PubMed ID: 28376866
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity in a phase I trial of continuous infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer.
Clamon GH; Baatz L; Hoffman HT; Hussey DH; Glascock M; McCulloch TM; Graham SM
Head Neck; 1996; 18(3):236-41. PubMed ID: 8860764
[TBL] [Abstract][Full Text] [Related]
16. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.
Rischin D; Peters LJ; O'Sullivan B; Giralt J; Fisher R; Yuen K; Trotti A; Bernier J; Bourhis J; Ringash J; Henke M; Kenny L
J Clin Oncol; 2010 Jun; 28(18):2989-95. PubMed ID: 20479425
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study.
Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ
Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
[TBL] [Abstract][Full Text] [Related]
19. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
20. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function.
Samant S; Kumar P; Wan J; Hanchett C; Vieira F; Murry T; Wong FS; Robbins KT
Head Neck; 1999 Oct; 21(7):595-601. PubMed ID: 10487945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]